|
|
||||||||
The Journal of Neurophysiology Vol. 87 No. 6 June 2002, pp. 2851-2857
Copyright ©2002 by the American Physiological Society
Neuroscience Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112
| |
ABSTRACT |
|---|
|
|
|---|
Chen, Chu,
Jeffery C. Magee, and
Nicolas
G. Bazan.
Cyclooxygenase-2 Regulates Prostaglandin E2 Signaling
in Hippocampal Long-Term Synaptic Plasticity.
J. Neurophysiol. 87: 2851-2857, 2002.
The functional significance of cyclooxygenases (COX-1 and -2),
the key enzymes that convert arachidonic acid (AA) to prostaglandins (PGs) in brain, is unclear, although they have been implicated in
cellular functions and in some neurologic disorders, including stroke,
epilepsy, and Alzheimer's disease. Recent evidence that COX-2 is
expressed in postsynaptic dendritic spines (which are specialized
structures involved in synaptic signaling) and is regulated by synaptic
activity implies participation of COX-2 in neuronal plasticity.
However, direct evidence is lacking. Here we demonstrate that selective
COX-2 inhibitors significantly reduced postsynaptic membrane
excitability, back-propagating dendritic action potential-associated
Ca2+ influx, and long-term potentiation (LTP)
induction in hippocampal dentate granule neurons, while a COX-1
inhibitor is ineffective. All of these actions were effectively
reversed by exogenous application of PGE2 but not
of PGD2 or PGF2
. Our
results indicate that COX-2-generated PGE2
regulates membrane excitability and long-term synaptic plasticity in
hippocampal perforant path-dentate gyrus synapses.
| |
INTRODUCTION |
|---|
|
|
|---|
Cyclooxygenase (COX) is the key
enzyme that converts arachidonic acid (AA) to prostaglandins (PGs). Two
isozymes of COX have been identified (Vane et al. 1998
).
COX-1 is constitutively expressed in most tissues and is thought to
mediate "housekeeping" functions. On the other hand, COX-2, an
inducible enzyme, participates in the injury/inflammatory response
(Smith et al. 1996
; Vane et al. 1998
).
Growing evidence, however, suggests that the functional significance of
COX-2 is far beyond what was initially revealed (Bazan
2001
; Dubois et al. 1998
; Ho et al.
1999
; Vane et al. 1998
). In the brain, COX-2 is
expressed in discrete populations of neurons and is enriched in the
cortex and hippocampus (Yamagata et al. 1993
) and has
been implicated in brain functions and in neurologic disorders,
including stroke, seizures, and Alzheimer's disease (Hewett et
al. 2000
; Ho et al. 1999
; Iadecola et al.
2001
; Miettnen et al. 1997
; Nakayama et
al. 1998
). However, the mechanisms by which COX and PGs
participate in neuronal cell signaling are still not clear.
Unlike in most tissues, "inducible" COX-2 is also constitutively
expressed in brain (Yamagata et al. 1993
), kidney
(Dlnchuk et al. 1995
; Morham et al.
1995
), and a few other organs (Dubios et al.
1998
; Vane et al. 1998
), suggesting that its
basal activity is engaged in cellular functions. Gene-deletion studies,
for instance, show that mice lacking COX-2 have severe renal
abnormalities and a consequently short life span (Dlnchuk et al.
1995
; Morham et al. 1995
; Vane et al.
1998
). In the brain, basal expression of COX-2 has been shown
to be regulated by synaptic activity, and its expression is upregulated
by a high-frequency stimulation (HFS) that is associated with long-term
potentiation (LTP) induction (Yamagata et al. 1993
).
Moreover, COX-2 is localized in neuronal dendritic spines where active
synapses are present (Kaufmann et al. 1996
). These
studies imply that both constitutive and inducible COX-2 may
participate in synaptic modifications. However, direct evidence is
still lacking. Here we report that selective COX-2 inhibitors
significantly reduced postsynaptic membrane excitability, back-propagating dendritic action potential-associated
Ca2+ influx, and LTP induction in hippocampal
dentate granule neurons, whereas a COX-1 inhibitor is ineffective. All
of these actions were effectively reversed by exogenous application of
PGE2 but not of PGD2 or
PGF2
. Our results indicate that
COX-2-generated PGE2 regulates postsynaptic
membrane excitability and long-term synaptic plasticity in hippocampal
perforant path-dentate gyrus synapses.
| |
METHODS |
|---|
|
|
|---|
Hippocampal slice preparation
Hippocampal slices were prepared from male c-57 mice (2-3 mo;
body wt, 25-34 g) using standard procedures as described previously (Chen et al. 2001
). Briefly, the brain was rapidly
removed after decapitation and placed in cold oxygenated (95%
O2-5% CO2)
low-Ca2+/high-Mg2+ slicing
solution composed of (in mM) 2.5 KCl, 7.0 MgCl2,
28.0 NaHCO3, 1.25 NaH2PO4, 0.5 CaCl2, 7.0 glucose, 3 pyruvic acid, 1 ascorbic
acid, and 234 sucrose. Then, slices were cut at a thickness of 400 µm
and transferred to a holding chamber in an incubator containing
oxygenated artificial cerebrospinal fluid (ACSF) composed of (in mM)
125.0 NaCl, 2.5 KCl, 1.0 MgCl2, 25.0 NaHCO3, 1.25 NaH2PO4, 2.0 CaCl2, 25.0 glucose, 3 pyruvic acid, and 1 ascorbic acid at 36°C. Slices were maintained in an incubator
containing oxygenated ACSF at room temperature (~22-24°C) for
1.5 h before recordings. Slices were then transferred to a recording
chamber where they were continuously perfused with the 95%
O2-5% CO2-saturated
standard ACSF at ~34-35°C. Individual dentate granule cells were
viewed with a Zeiss Axioskop microscope, fitted with a ×60 (Olympus) water-immersion objective and differential interference contrast (DIC) optics.
Electrophysiologic recordings
Whole cell patch-clamp recordings were made using an
Axoclamp-2B patch-clamp amplifier in bridge mode. Recording
pipettes (6-9 M
) were pulled from borosilicate glass with a
micropipette puller (Sutter Instrument) and fire polished on a
microforge (Narishige Scientific Instrument) prior to use. The internal
pipette solution contained (in mM) 120 K gluconate, 20 KCl, 4 NaCl, 10 HEPES, 0.5 EGTA, 0.28 CaCl2, 4 Mg2ATP, 0.3 Tris2GTP, and
14 phosphocreatine (pH 7.25 with KOH). Series resistance ranged from 15 to 30 M
as estimated directly from the amplifier and was monitored
during recordings by injection of a hyperpolarizing current (50 pA)
before delivery of a stimulus. The resting membrane potential for
recorded cells was around
74 mV. Excitatory postsynaptic potentials
(EPSPs) were recorded in response to stimulation of the perforant path at a frequency of 0.05 Hz. Stimuli were elicited via a bipolar tungsten
electrode placed in the middle of the molecular layer. The amplitude
range of the evoked EPSPs was always adjusted to 2-6 mV (<30% of
threshold for generating an action potential). LTP in the perforant
path was induced by a HFS (consisting of 8 trains, each of 8 pulses at
200 Hz with an intertrain interval of 2 s) paired with
postsynaptic depolarizing current injection (0.5 nA). LTP was
operationally defined as >20% increase above baseline for the
amplitude of EPSPs from 26 to 30 min after HFS. In experiments where
selective COX-1 and -2 inhibitors were applied, slices were pretreated
with NS398, nimesulide (Nims), or indomethacin (Indo) for
1.5 h and
then were continuously perfused with the inhibitors during recordings.
All the bath-perfused solutions, including drug solutions, contained 10 µM bicuculline to block ionotropic GABA receptors.
Ca2+ imaging
Changes in [Ca2+]i
in postsynaptic neurons during somatic depolarizing current injection
were imaged with the fluorescent dye fura-2 (~100 µM) in the
recording pipette as described previously (Magee and Johnston
1997
). The internal pipette solution for the Ca2+ imaging contained (in mM) 120 K gluconate,
20 KCl, 4 NaCl, 10 HEPES, 4 Mg2ATP, 0.3 Tris2GTP, 14 phosphocreatine, and 3 ascorbic acid
(pH 7.25 with KOH). A cooled charge-coupled device (CCD) camera
(Photometrics, Tucson, AZ) in a sequential frame-transfer mode was used
to record high-speed fluorescence images. Relative changes in
[Ca2+]i were quantified
as changes in
F/F, where F is
fluorescent intensity before stimulation (after subtraction of
autofluorescence) and
F is the change from this value
during neuron firing. The tissue autofluorescence was determined by an
equivalent measurement at a parallel location in the slice that was
away from the dye-filled neuron. A 380-nm light (13-nm band-pass
filter; Omega Optical) was used to excite fura-2. Sequential frame rate
for optical recordings was one frame every 25 ms and pixels were binned
in a 5-by-5 array. Action potential-induced dendritic
Ca2+ influx was imaged at cell body and at 25, 50, 100, and 125 µm or beyond from the cell body. Data were presented
as means ± SE. Unless stated otherwise, Student's
t-test and one-way ANOVA with Student-Newman-Keuls test were
used for statistical comparison when appropriate. Differences were
considered significant when P < 0.05. The care and use
of the animals reported in this study were approved by the
Institutional Animal Care and Use Committee of Louisiana State
University Health Sciences Center.
| |
RESULTS |
|---|
|
|
|---|
Selective COX-2 inhibitors, but not those of COX-1, reduce LTP induction in hippocampal dentate granule neurons
To determine whether COX-2 participates in long-term synaptic
plasticity in hippocampal perforant path-dentate gyrus synapses, mouse
hippocampal slices were pretreated with a selective COX-2 inhibitor,
NS398 (10 µM, a concentration above IC50 for
COX-2 but below IC50 for COX-1) (Vane et
al. 1998
) for
1 h and continuously perfused in the recording
bath. NS398 did not elicit an effect on baseline EPSPs. However, HFS
paired with postsynaptic depolarizing current injection (0.5 nA)-induced enhancement of the EPSP amplitude was significantly reduced
from 26 to 30 min after HFS in cells treated with NS398 (141 ± 13%, n = 16) when compared with controls (229 ± 21%, n = 18). The enhancement of the EPSP amplitude
was further decreased to 121 ± 16% (n = 9) when
the concentration of NS398 was raised to 30 µM (Fig.
1, C and D). To
confirm that the NS398-induced inhibition of LTP induction is due to
COX-2 inhibition, we employed another selective COX-2 inhibitor,
nimesulide (Nims). Similar to the effects of NS398, Nims (30 µM)
reduced HFS-induced potentiation of EPSP amplitude to 106 ± 18%
(n = 8). We operationally defined LTP induction as
>20% increase above baseline amplitude of EPSPs from 26 to 30 min
after HFS. Thus it appears that selective COX-2 inhibitors
significantly reduced the probability of LTP induction in hippocampal
dentate granule neurons (Fig. 1B).
|
To further assess the significance of COX-2, we used indomethacin
(Indo), a relatively effective COX-1 inhibitor (Meade et al.
1993
; Yamagata et al. 1993
). Application of 1 µM indo (IC50 for COX-1: 0.028 µM and for
COX-2: 1.68 µM) had little effect on HFS-induced potentiation of EPSP
amplitude (210 ± 16%, n = 18) and probability of
LTP induction (Fig. 1).
PGE2 selectively reverses COX-2 inhibitor-induced suppression of LTP
If the effects of COX-2 inhibition on LTP induction in hippocampal
dentate granule neurons result from blocking the synthesis of PGs, then
exogenous application of PGs should restore the COX-2 inhibitor-induced
suppression of LTP induction. To test this hypothesis, we individually
applied three different PGs in the presence of NS398 (10 µM). As
indicated in Fig. 2, bath application of
PGE2 (0.33 µM) significantly reversed NS398 (10 µM)-induced reduction of EPSP potentiation (242 ± 29%,
n = 12 vs. 141 ± 13%, n = 16) and probability of LTP induction (100%, 12 of 12 cells vs. 50%, 8 of
16 cells), whereas it had little effect on baseline EPSPs. Bath
applications of PGD2 (0.33 µM) or
PGF2
(0.33 µM) did not significantly
increase HFS-induced enhancement of EPSP amplitudes and probability of
LTP induction. Because COX-2 converts AA to PGE2
(Brock et al. 1999
) and PGE2
receptors (EP) are expressed in the hippocampus (Narumiya et al.
1999
; Zhang and Rivest 1999
), it is likely that
PGE2 is the main messenger in COX-2-mediated activity-dependent synaptic plasticity.
|
Action of PGE2 on synaptic modification is not on presynaptic sites
It has been proposed that the bioactive lipids AA and
platelet-activating factor (PAF) are retrograde messengers that
modulate hippocampal long-term synaptic plasticity (Bazan
1995
; Kato et al. 1994
; O'Dell et al.
1991
; Williams et al. 1989
). To determine whether the role of COX-2 in regulating PG signaling in hippocampal synaptic plasticity is similar to that of other bioactive lipids, we
examined the effects of postsynaptic application of
PGE2 on spontaneous miniature EPSPs (mEPSPs). As
shown in Fig. 3, when included in the
recording pipette solution, 2 µM PGE2 did not induce significant effects on frequency or amplitude of mEPSPs during
20-min recordings (Kato et al. 1994
). We also used
paired-pulse protocol (inter-pulse interval, 80-100 ms) to examine the
presynaptic effect of COX-2 inhibition (Chen et al.
2001
; Zucker 1989
). We did not detect
differences in the ratios of the paired-pulse facilitation in the
absence or presence of COX-2 inhibitors (control: 1.04 ± 0.03, n = 11; 10 µM NS398: 1.01 ± 0.02, n = 16). This indicates that the action of COX-2
reaction products on synaptic modification does not involve presynaptic
terminals but postsynaptic sites.
|
COX-2 inhibition reduces postsynaptic membrane excitability
It has been demonstrated that PGE2 regulates
membrane excitability by modulating K+,
Ih, and TTX-resistant
Na+ channel currents in sensory neurons
(Gold et al. 1998
; Ingram and Williams
1996
; Nicol et al. 1997
). Recent evidence
reveals the importance of spatiotemporal correlation of coincidence of postsynaptic firing and EPSPs in synaptic efficacy (Bi and Poo 2001
; Koester and Sakmann 1998
; Magee and
Johnston 1997
; Markram et al. 1997
). Thus
reducing postsynaptic membrane excitability, which causes a decrease in
the number of the postsynaptic action potentials (APs) during
presynaptic HFS, decreases the probability of LTP induction. To
determine whether the inhibition of COX-2 activity altered postsynaptic
membrane excitability, we examined the number of APs elicited by
presynaptic HFS paired with postsynaptic current injection. As
illustrated in Fig. 4, NS398 (10 and 30 µM) and Nims (30 µM) significantly reduced the number of APs, whereas Indo had little effect on the membrane excitability. Bath application of PGD2 or
PGF2
(0.33 µM) did not recover NS398 (10 µM)-induced reduction in the number of APs. Correlated to LTP
induction, PGE2 (0.33 µM) significantly
reversed NS398 (10 µM)-induced decrease in the number of APs (Fig.
4). These data suggest that basal activity of COX-2 plays an important
role in regulating membrane excitability and that COX-2
inhibitor-mediated inhibition of LTP induction may result from reduced
postsynaptic membrane excitability. The reduction of postsynaptic
membrane excitability caused a decrease in the synchrony of the
coincidence of EPSPs and postsynaptic APs that regulates synaptic
efficacy (Bi and Poo 2001
; Koester and Sakmann
1998
; Markram et al. 1997
). To evaluate this
hypothesis, we reduced the amount of postsynaptic current injection
from 0.5 to 0.3 nA during presynaptic HFS. Reduction of postsynaptic
depolarizing current injection caused a reduction in the number of APs
and consequent LTP induction. Further, we increased postsynaptic
depolarizing current injection from 0.5 to 0.8 nA in cells treated with
NS398 (10 µM). An increase in the current injection induced an
increase in the number of APs and LTP induction (Figs. 2, C
and D, and 4, A and B). Therefore a
correlation existed between the number of postsynaptic spikes during
the tetanus and the magnitude of EPSP potentiation (Fig. 4F). To further examine effects of COX-2-generated
PGE2 on postsynaptic membrane properties, we
measured membrane input resistance and the amount of current required
to trigger an AP (current threshold). NS398 (10 µM) reduced the
membrane input resistance and increased the current threshold.
PGE2 (0.33 µM) significantly reversed
NS398-induced decrease in input resistance and increase in current
threshold (Fig. 4G). This finding suggests that
PGE2 derived from the tonic activity of
constitutive COX-2 contributes to the membrane excitability.
|
COX-2 inhibition reduces back-propagating dendritic action potential-associated Ca2+ influx
Active propagation of axonally initiated APs back into the
dendrites and associated dendritic Ca2+ influx
play a critical role in hippocampal LTP induction (Magee and
Johnston 1997
). To test whether the COX-2 inhibitor-induced decrease in postsynaptic membrane excitability resulted in an inhibition of back-propagating dendritic APs, dendritic
[Ca2+]i changes were
imaged during somatic depolarizing current injection. As indicated in
Fig. 5, NS398 (10 µM) significantly
decreased dendritic Ca2+ influx at 100 µm
(normalized
F/F: 0.54 ± 0.03, n = 8) and >125 µm (0.34 ± 0.08, n = 4) from soma when compared with the control (0.79 ± 0.02, n = 9 and 0.64 ± 0.06, n = 8, respectively). Bath application of
PGE2 (0.33 µM) restored dendritic
Ca2+ influx to control level (0.75 ± 0.04, n = 11 and 0.56 ± 0.05, n = 9 at
100 and >125 µm, respectively). These optical
Ca2+-imaging data indicate that NS398
significantly decreased back-propagating dendritic AP amplitudes and
associated Ca2+ influx and that
PGE2 was able to rescue the COX-2
inhibitor-induced inhibition.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our findings provide the first direct evidence that COX-2, but not COX-1, regulates PG signaling in hippocampal long-term synaptic plasticity. Our data also reveal that COX-2-generated PGE2 is an important signaling molecule in modifying synaptic efficacy because it effectively reversed selective COX-2 inhibitor-induced decreases in the number of APs during HFS, back-propagating dendritic AP-associated Ca2+ influx, and LTP induction. It is likely that COX-2 participates in hippocampal synaptic plasticity through regulation of PGE2 signaling in modulating postsynaptic membrane excitability. Thus the inhibition of COX-2 activity induces the reduction of PGE2 level that causes a decrease in postsynaptic membrane excitability. This, in turn, reduces the number of APs or back-propagating dendritic AP amplitude and associated Ca2+ influx through voltage-gated Ca2+ channels and N-methyl-D-aspartate receptors (NMDA), which is critical for the induction of LTP.
It appears that COX-2 generated PGE2 does not
serve as a retrograde messenger to act on presynaptic sites as AA and
PAF do (Bazan 1995
; Kato et al. 1994
;
O'Dell et al. 1991
; Williams et al.
1989
) because the inhibition of COX-2 with selective COX-2 inhibitors or exogenous application PGE2 did not
elicit changes in the amplitude and frequency of mEPSPs or the ratios
of paired-pulse facilitation before and after HFS. However, these
manipulations did induce the change in the number of postsynaptic
membrane APs during HFS, indicating that COX-2 reaction products may
act on the postsynaptic sites.
In the present study, we observed that the number of APs during HFS
paired with postsynaptic current injection was reduced in slices
pretreated with the COX-2 inhibitor. Because this is a rapid response
and the action occurs within a few milliseconds, it is unlikely that
this reduction was due to the blockade of new synthesis of enzyme
derived from the inducible COX-2. We know that prostanoids are not
classic neurotransmitters. They are not stored in or secreted from
synaptic vesicles. Once synthesized, they diffuse rapidly to and
activate their specific membrane receptors. This means that
PGE2 signaling in this rapid response must be dependent on basal COX-2 expression rather than on the inducible COX-2
expression (Yamagata et al. 1993
). This postulation has been supported by evidence that both COX-2 mRNA and protein in unstimulated brain are expressed at relatively high levels in a number
of neurons involved in cognitive functions, including hippocampal
granule, pyramidal cells, and cortical neurons. In particular, COX-2
protein is expressed at a very high level in dentate granule cells
under basal conditions (Yamagata et al. 1993
). In
addition, COX-2 is consistently localized in dendritic spines of
neurons that receive synaptic input (Kaufmann et al. 1996
). Our results, that the membrane input resistance and
current threshold had altered before HFS in slices pretreated with the COX-2 inhibitor, also provide evidence that basal activity of COX-2-generated PGE2 may dynamically regulate
membrane excitability. Because COX-2 expression is upregulated rapidly
by HFS that is associated with LTP induction (Yamagata et al.
1993
), it is possible that constitutive COX-2 may contribute to
the induction of LTP as we observed in the present study and that
inducible COX-2 may contribute to the maintenance of LTP.
One possibility for the COX-2 inhibitor-induced reduction of LTP may be
due to its acting on postsynaptic NMDA receptor channels because the
perforant path-dentate LTP is dependent on the NMDA receptors. We have
tested this possibility and found that the number of APs elicited
during LTP-inducing stimulation trains in the presence of the NMDA
receptor antagonist 2-amino-5-phosphonovaleric acid (APV, 50 µM) and
NS398 (10 µM) was similar to that of NS398 alone (data not shown). In
addition, we also tested the possibility that the COX-2 inhibitors
affected adrenergic receptors because the perforant path-dentate LTP
has been shown to, in part, depend on
-adrenergic receptors
(Stanton and Sarvey 1985
). Application of the
-adrenergic receptor antagonist, propranolol (1 µM) did not induce
a change in the number of spikes during LTP-inducing stimulation trains
in the absence and presence of NS398 (data not shown). Thus it is
unlikely that the COX-2 inhibitor-induced changes in membrane
excitability and long-term plasticity result from their directly acting
on the NMDA or
-adrenergic receptors. Recent progress in synaptic
physiology reveals that the back-propagating dendritic APs are a
critical element in the induction of long-term synaptic plasticity in
hippocampal pyramidal neurons (Magee and Johnston 1997
).
Postsynaptic APs are initiated in the axon and then propagate back into
the dendritic arbor of neurons, evoking an activity-dependent dendritic
Ca2+ influx. An elevation of the postsynaptic
intracellular free [Ca2+] contributes to
long-lasting changes in the efficacy of glutamatergic synapses. In
hippocampal CA1 pyramidal neurons, transient A-type K+ channels and hyperpolarization-activated
cation channels increase their density with the distance from soma to
distal dendrites (Hoffman et al. 1997
; Magee
1998
), and they shape EPSPs and modulate the back-propagating
dendritic APs via protein kinases A and C (PKA and PKC) (Hoffman
and Johnston 1998
). AA, the precursor of PGs, has been shown to
alter the availability of transient and sustained dendritic
K+ channels that may underlie AA-induced increase
in the amplitude of back-propagating dendritic APs (Colbert and
Pan 1999
). In sensory neurons, PGE2
regulates membrane excitability through the cAMP-mediated modulation of
ionic conductances, including K+,
Ih, and TTX-resistant
Na+ channel currents (Gold et al.
1998
; Ingram and Williams 1996
; Nicol et
al. 1997
). Thus it is likely that selective COX-2
inhibitor-induced decrease in the postsynaptic membrane excitability
may result from a relief of PGE2 modulation of
these channels; consequently, reduced postsynaptic membrane
excitability would cause decreases in the number and amplitude of
back-propagating dendritic APs, resulting in the reduction of the
probability of LTP induction in hippocampal dentate granule neurons.
Although we did not examine the effects of the COX-2 inhibition or
PGE2 on K+,
Ih, or Na+
channel activities in the present study, it would be interesting to
investigate the COX-2 reaction-product modulation of these channels in
hippocampal neurons.
Our data reveal that basal activity of constitutively inducible COX-2 plays an important role in regulating membrane excitability and activity-dependent LTP induction in the hippocampus. These findings will further our understanding of physiologic and pathologic events mediated by COX and the significance of PGs in memory storage and neurologic diseases.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. Elena B. Rodriguez de Turco for helpful comments on the manuscript and V. Marcheselli for technical help.
This work was supported by National Institute of Neurological Disorders and Stroke Grant R01NS-23002 and National Science Foundation Grant NSF/Louisiana Education Quality Support Fund (LEQSF) (2001-04)-RII-01 [Experimental Program to Stimulate Competitive Research (EPSCoR)].
| |
FOOTNOTES |
|---|
Address for reprint requests: C. Chen, Neuroscience Center, Louisiana State University Health Sciences Center, 2020 Gravier St., Suite D, New Orleans, LA 70112 (E-mail: cchen{at}lsuhsc.edu).
Received 9 October 2001; accepted in final form 7 February 2002.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Ishida, T. Sato, M. Irifune, K.-i. Tanaka, N. Nakamura, and T. Nishikawa Effect of acetaminophen, a cyclooxygenase inhibitor, on Morris water maze task performance in mice J Psychopharmacol, September 1, 2007; 21(7): 757 - 767. [Abstract] [PDF] |
||||
![]() |
D. Albrecht Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO Learn. Mem., March 8, 2007; 14(3): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akaneya and T. Tsumoto Bidirectional Trafficking of Prostaglandin E2 Receptors Involved in Long-Term Potentiation in Visual Cortex J. Neurosci., October 4, 2006; 26(40): 10209 - 10221. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sang and C. Chen Lipid Signaling and Synaptic Plasticity Neuroscientist, October 1, 2006; 12(5): 425 - 434. [Abstract] [PDF] |
||||
![]() |
N. Sang, J. Zhang, and C. Chen PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons J. Physiol., May 1, 2006; 572(3): 735 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sang, J. Zhang, V. Marcheselli, N. G. Bazan, and C. Chen Postsynaptically Synthesized Prostaglandin E2 (PGE2) Modulates Hippocampal Synaptic Transmission via a Presynaptic PGE2 EP2 Receptor J. Neurosci., October 26, 2005; 25(43): 9858 - 9870. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Gois, M. K.-H. Schafer, N. Defamie, C. Chen, A. Ricci, E. Weihe, H. Varoqui, and J. D. Erickson Homeostatic Scaling of Vesicular Glutamate and GABA Transporter Expression in Rat Neocortical Circuits J. Neurosci., August 3, 2005; 25(31): 7121 - 7133. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Bekar, M. E. Loewen, K. Cao, X. Sun, J. Leis, R. Wang, G. W. Forsyth, and W. Walz Complex Expression and Localization of Inactivating Kv Channels in Cultured Hippocampal Astrocytes J Neurophysiol, March 1, 2005; 93(3): 1699 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen and N. G. Bazan Endogenous PGE2 Regulates Membrane Excitability and Synaptic Transmission in Hippocampal CA1 Pyramidal Neurons J Neurophysiol, February 1, 2005; 93(2): 929 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Iadecola and P. B. Gorelick The Janus Face of Cyclooxygenase-2 in Ischemic Stroke: Shifting Toward Downstream Targets Stroke, February 1, 2005; 36(2): 182 - 185. [Full Text] [PDF] |
||||
![]() |
A. Vazquez-Tello, L. Fan, X. Hou, J.-S. Joyal, J. A. Mancini, C. Quiniou, R. I. Clyman, F. Gobeil Jr., D. R. Varma, and S. Chemtob Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1155 - R1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. McCullough, L. Wu, N. Haughey, X. Liang, T. Hand, Q. Wang, R. M. Breyer, and K. Andreasson Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia J. Neurosci., January 7, 2004; 24(1): 257 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Bazan Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor J. Lipid Res., December 1, 2003; 44(12): 2221 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Newton, E. F. Collier, J. Hunsberger, D. Adams, R. Terwilliger, E. Selvanayagam, and R. S. Duman Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors J. Neurosci., November 26, 2003; 23(34): 10841 - 10851. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sanchez-Moreno, M. P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin High-Pressurized Orange Juice Consumption Affects Plasma Vitamin C, Antioxidative Status and Inflammatory Markers in Healthy Humans J. Nutr., July 1, 2003; 133(7): 2204 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. McGeer and E. G. McGeer Innate Immunity, Local Inflammation, and Degenerative Disease Sci. Aging Knowl. Environ., July 24, 2002; 2002(29): re3 - 3. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||